Phillips-Medisize Corporation (the “Company”) announced it has completed its previously announced acquisition of Injectronics Corporation (“Injectronics”). Terms of the transaction were not disclosed.
This acquisition expands Phillips-Medisize’s footprint, providing purpose-built facilities in the Northeastern United States, a global center of biopharmaceutical and medical device innovation, and opportunities for continued growth in these areas.
“This transaction, just like the recent acquisition of Medicom Innovation Partner, is consistent with Phillips- Medisize’s strategy of continued growth through the development of our people, the build-out of our processes and capabilities, and our investment in purpose-built facilities,” said Matt Jennings, Chairman, CEO and President of Phillips-Medisize Corporation. “Injectronics and Phillips-Medisize have similar cultures, with a passion for excellence and a focus on quality, service and innovation. Our shared qualities will ensure a seamless transition and I am very excited to welcome the Injectronics team on board.”
For more information, click here